Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Non-cash Items (2016 - 2025)

Firefly Neuroscience has reported Non-cash Items over the past 11 years, most recently at $41000.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $41000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $41000.0 (changed N/A YoY), and the annual figure for FY2025 was $41000.0, changed.
  • Non-cash Items for Q4 2025 was $41000.0 at Firefly Neuroscience, down from $91000.0 in the prior quarter.
  • Over the last five years, Non-cash Items for AIFF hit a ceiling of $5.2 million in Q4 2021 and a floor of $41000.0 in Q4 2025.
  • Median Non-cash Items over the past 4 years was $346000.0 (2021), compared with a mean of $881687.8.
  • Biggest five-year swings in Non-cash Items: skyrocketed 226.49% in 2021 and later crashed 98.15% in 2022.
  • Firefly Neuroscience's Non-cash Items stood at $5.2 million in 2021, then crashed by 98.15% to $95937.0 in 2022, then skyrocketed by 547.3% to $621000.0 in 2024, then tumbled by 93.4% to $41000.0 in 2025.
  • The last three reported values for Non-cash Items were $41000.0 (Q4 2025), $91000.0 (Q3 2025), and $225000.0 (Q1 2025) per Business Quant data.